Literature DB >> 33552485

CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient.

Shravan Dave1, Abbey Barnard1, Michel Mendler1.   

Abstract

Watch a video presentation of this article Watch an interview with the author.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2021        PMID： 33552485      PMCID： PMC7849299          DOI： 10.1002/cld.966

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  17 in total

1.  Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation.

Authors:  Krista L Lentine; Salvatore P Costa; Matthew R Weir; John F Robb; Lee A Fleisher; Bertram L Kasiske; Robert L Carithers; Michael Ragosta; Kline Bolton; Andrew D Auerbach; Kim A Eagle
Journal:  Circulation       Date:  2012-07-02       Impact factor: 29.690

Review 2.  Can coronary computed tomography angiography replace invasive angiography? Yes: it is all about finding the right test for the right person at the right time.

Authors:  Stephan Achenbach
Journal:  Circulation       Date:  2015-01-27       Impact factor: 29.690

Review 3.  Management of disordered hemostasis and coagulation in patients with cirrhosis.

Authors:  Nicolas M Intagliata; Stephen H Caldwell
Journal:  Clin Liver Dis (Hoboken)       Date:  2014-06-25

Review 4.  Evaluation of coronary artery disease in potential liver transplant recipients.

Authors:  Brian J Hogan; Enoka Gonsalkorala; Michael A Heneghan
Journal:  Liver Transpl       Date:  2017-03       Impact factor: 5.799

5.  Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Paul Martin; Andrea DiMartini; Sandy Feng; Robert Brown; Michael Fallon
Journal:  Hepatology       Date:  2014-03       Impact factor: 17.425

6.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

7.  Preoperative coronary calcium score is predictive of early postoperative cardiovascular complications in liver transplant recipients.

Authors:  Y-G Kong; J-W Kang; Y-K Kim; H Seo; T-H Lim; S Hwang; G-S Hwang; S-G Lee
Journal:  Br J Anaesth       Date:  2014-11-21       Impact factor: 9.166

8.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

9.  Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding.

Authors:  Alexander B Benson; Gregory L Austin; Mary Berg; Kim K McFann; Sila Thomas; Gina Ramirez; Hugo Rosen; Christopher C Silliman; Marc Moss
Journal:  Intensive Care Med       Date:  2010-07-24       Impact factor: 17.440

Review 10.  Non-alcoholic fatty liver disease and cardiovascular risk.

Authors:  Rashmee Patil; Gagan K Sood
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.